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Molecular mechanisms underlying apoptosis in retinitis pigmen-
tosa, as in other neurodegenerative diseases, are still elusive, and
this fact hampers the development of a cure for this blinding
disease. We show that two apoptotic pathways, one from the
mitochondrion and one from the endoplasmic reticulum, are co-
activated during the degenerative process in an animal model of
retinitis pigmentosa, the rd1 mouse. We found that both AIF and
caspase-12 translocate to the nucleus of dying photoreceptors in
vivo and in an in vitro cellular model. Translocation of both
apoptotic factors depends on changes in intracellular calcium
homeostasis and on calpain activity. Knockdown experiments
defined that AIF plays the major role in this apoptotic event,
whereas caspase-12 has a reinforcing effect. This study provides a
link between two executor caspase-independent apoptotic path-
ways involving mitochondrion and endoplasmic reticulum in a
degenerating neuron.
rd1 mouse  photoreceptor  retinal stem cells
Retinitis pigmentosa (RP) is a form of retinal degenerationresulting from rod photoreceptor cell death and leading to
blindness. Despite the remarkable genetic heterogeneity of this
disease, photoreceptors undergo a common mode of cell death:
apoptosis. An autosomal recessive form of RP is caused by muta-
tions in the rod-specific -catalytic subunit of the phosphodiester-
ase gene PDE6B (1). The naturally occurring retinal degeneration
(rd1) mouse is the animal model for this type of RP (2). The rd1
mouse has elevated levels of cGMP (3, 4), and this elevation results
in elevated intracellular calcium (5). Ca2 concentration within the
cytosol aswell asCa2 tides and ebbswithin various organelles, such
as mitochondria, nucleus, and endoplasmic reticulum (ER), are
important in regulating many cellular functions such as neuronal
survival or cell death.
There are instances, most notably after Ca2 overload, in which
the cell-death pathway elicited differs from classical caspase-
mediated apoptosis. Calpains are cysteine proteases activated by
calcium during apoptotic processes (6). Calpain I and II (- and
m-calpain) are expressed in the retina (7), and recent reports
showed activation of calpain and cathepsin D in rd1 mice (5, 8).
Several proteins are known targets of calpain protease activity, such
as caspase-12 and apoptosis-inducing factor (AIF). Caspase-12,
localized to the ER (9), can be activated by m-calpain in the
presence of the pancaspase inhibitor zVAD.fmk (10). Interestingly,
caspase-12 has been linked to neuronal degeneration in neurotox-
icity caused by amyloid- protein (9), by prion protein (11), and in
animal models of ALS (12). The cleaved active form of caspase-12
participates to the apoptotic event by translocation to the nucleus
(13); however, it is unclear whether caspase-12 can induce chro-
matin fragmentation. AIF also directly translocates to the nucleus
to execute DNA fragmentation that culminates in cell death (14).
The translocation of AIF from mitochondria to the nucleus has
been implicated in neuronal demise and in photoreceptor cell death
after retinal detachment (15–17). Cleavage and release ofAIF from
mitochondria is regulated by -calpain (18) and can occur inde-
pendently from cytochrome c release (19).
In this study, we demonstrate a direct correlation of increased
intracellular Ca2, calpain activation, and nuclear translocation of
AIF and caspase-12 in apoptotic photoreceptors.We also show that
AIF plays the key role in apoptosis activation. Finally, we provide
evidences that treatment with calpain inhibitors is able to block
activation of AIF and caspase-12 and, consequently, apoptosis in
vitro and in vivo.
Results
AIF and Caspase-12 Are Activated During Apoptosis in rd1 Retinas. To
investigate which apoptotic pathway is activated during the degen-
erative process in rd1 retinas, we analyzed changes in subcellular
localization of two factors involved in intrinsic apoptotic signals,
AIF and caspase-12. Based on our analysis of apoptosis progression
and on other reports (20), we chose P11 for all our studies. At this
stage, rods are undergoing apoptosis, followed then by cones not
expressing Pde6b (21). AIF is a mitochondrial protein mostly
localized in the inner segment of photoreceptor cells containing
mitochondria and ER and in the cytoplasm of other retinal cells
(Fig. 1A; and see Fig. 6A, which is published as supporting
information on the PNAS web site). In rd1 retinas, AIF could be
detected in some photoreceptor nuclei and colocalized with
TUNEL that labels chromatin fragmentation in cells undergoing
apoptosis (Figs. 1 E–H and 6B). Similarly, in wild-type (wt) mice,
caspase-12 is preferentially found in the inner segment containing
the ER of photoreceptor cells (Figs. 1B and 6C). Double labeling
with TUNEL showed caspase-12 in the nucleus of rd1 cells under-
going apoptosis (Figs. 1 F–H and 6D). Interestingly, we found that
all nuclei containing activated AIF also contained activated
caspase-12. We calculated that 80% of the cells in apoptosis also
showed nuclear staining for AIF and caspase-12 (Fig. 1M). This
same analysis was performed also at postnatal day (P)10 and P13,
and we calculated similar percentages of AIF- and caspase-12-
positive nuclei (data not shown), suggesting that lack of detection
of AIF and caspase-12 in 20% of apoptotic photoreceptors is not
because of the time chosen for our analysis. Western blot analysis
confirmed nuclear localization of AIF and activated caspase-12
fragments in rd1 and not in the wt retinas (Fig. 1N). No activated
caspase-3 or caspase-9 were detectable in cytosol extracts from wt
and rd1 retinas (data not shown), as expected from other reports
(22, 23). Translocation of AIF and caspase-12 appeared specific; in
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fact, no changes in subcellular localizations of mitochondrial cyto-
chrome c and ER marker ERAB were observed in rd1 photore-
ceptors (Fig. 6 E–H).
Finally, we treated wt mice with nitrosomethyl-urea, causing
massive and fast apoptosis in the retina. In these conditions, almost
all photoreceptor nuclei were TUNEL-positive, but none of them
showed nuclear localization of either AIF or caspase-12 (Fig. 1
I–L), demonstrating that their translocation was specific to the
genetic pathological condition.
In Vitro Analysis of AIF and Caspase-12 Activation in rd1 Photorecep-
tors. To better characterize, at a molecular level, colocalization of
AIF and caspase-12 and the cells undergoing apoptosis, we took
advantage of an in vitro system to differentiate photoreceptor cells.
Neurospheres, derived from the adult ciliary margin were in
vitro-differentiated to the various retinal neuronal cell types (24).
Photoreceptors were characterized by expression of three different
markers (rhodopsin, Pde6, and cGMP-gated channel Cnga).
Approximately 40% of the wt cells in culture expressed the three
photoreceptor-specific proteins, whereas cells derived from rd1
mice expressed rhodopsin and Cnga, but not Pde6, as expected
(Fig. 2 A–E, G, H, J, and K). Interestingly, we found that only
rd1-differentiated cells were undergoing apoptosis in vitro (Fig. 2 F,
I, and L). All apoptotic cells were also expressing photoreceptor
markers, and apoptosis was never observed in cells labeled with
markers for amacrine and bipolar and horizontal retinal neurons
(Fig. 2 M–O).
Subcellular localizations of AIF and caspase-12 were analyzed in
wt and rd1 photoreceptors in vitro. In these experiments, cells were
treated with retinoic acid to achieve a faster and higher rod
differentiation. Both AIF and caspase-12 localized inside the
apoptotic nuclei of rd1 cells (Fig. 3 E–H, arrows) differently from
wt cells (Fig. 3A–D). As shown in vivo, also in in vitro-differentiated
photoreceptors AIF and caspase-12 colocalized in the apoptotic
nuclei (Fig. 3H, arrows). We also analyzed cytochrome c localiza-
tion, and we did not detect mitochondrial release of cytochrome c
during photoreceptor apoptosis (Fig. 3 I and J). This finding
confirmed the specificity of translocation ofAIF not affecting other
mitochondrial molecules, and this was true also for caspase-12 as
analyzed with an ER-localized protein (ERAB) (Fig. 3 K and L).
Finally, to define whether activation of AIF and caspase-12 was
correlated to changes in intracellular Ca2 concentration, we
compared Ca2 content between wt and rd1 in in vitro-
differentiated photoreceptors. A progressive increase in Ca2 con-
centration was detected in rd1 cells during differentiation (Fig. 3
M–O). We measured the enhancement in intracellular Ca2 levels
in rd1 cells of three times after 11 days in culture, and treatmentwith
cis-diltiazem, a calcium blocker, prevented calcium increase (Fig.
3O). Finally, by treatment of wt in vitro-differentiated photorecep-
tors with thapsigargin, which inhibits ER-associated Ca2-ATPase
Fig. 1. Translocation of AIF and caspase-12 in apoptotic photoreceptor nuclei of rd1 retina. (A–L) Confocal microscopy of P11 retinal sections triple stained with
antibodies anti-AIF (blue) or anti-caspase-12 (red) and TUNEL (green). Merged images are shown in D, H, and L, where white indicates triple labeling. is, inner
segment; onl, outer nuclear layer. (Scale bar, 100m.) (M) Percentage of AIF-labeled (blue), caspase-12-labeled (red), and double-labeled (white) apoptotic nuclei
(green) in rd1 mice. (N) Western blot of nuclear-enriched lysates purified from P11 wild-type (wt) and rd1 retinas. Western blot was normalized with nuclear
marker histone H3 (H3). Contaminations from mitochondria and cytosol were evaluated by analysis of a mitochondrial protein (C5) and -actin. Inactive form
of caspase-12 is shown in Western blot from total extract (tot, first lane).
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anddisruptsCa2 homeostasis (25), we observed cotranslocation of
AIF and caspase-12 inside apoptotic nuclei (Fig. 7, which is
published as supporting information on the PNAS web site). These
data confirmed a direct correlation of intracellular Ca2 concen-
tration and translocation of apoptotic factors inside the nuclei.
We tracked the sequence of events during photoreceptor apo-
ptosis. We found that, at 10 days of culture, the percentage of cells
with high Ca2 (Fig. 3N andQ) is similar to cells activating calpain
(Fig. 3 P and Q) and higher than TUNEL, nuclear AIF, and
caspase-12 cells. We also detected cells in which calpains were
activated but chromatin was not yet fragmented (Fig. 3P). At 9 and
10 days of differentiating culture, we observed a low percentage of
cells in which AIF and caspase-12 have a nuclear localization but
that are not yet labeled with TUNEL. Up-regulation of Caspase-12
mRNA in rd1 cells was also detected (Fig. 3R), as reported in
motor-neuron degeneration (12).
All together, our data show that increase of intracellular Ca2 in
differentiated rods is directly correlated to calpain activation and,
subsequently, to translocation of AIF and caspase-12 to nuclei.
Furthermore, lack of cytochrome c release from mitochondria
confirmed that translocations of AIF and caspase-12 are indepen-
dent of executor caspase activation.
Roles of AIF and Caspase-12 During the Degenerative Process. To
address the interaction between AIF and caspase-12 in degener-
ating photoreceptors, we used RNAi to knock down either AIF or
caspase-12 in in vitro-differentiated rd1 photoreceptors. Short hair-
pin (sh)RNAs showed high efficiency to knock downAIF (Fig. 4A,
D, and O) and caspase-12 (Fig. 4 H, K, and P). To rule out
Fig. 2. Apoptosis in in vitro-differentiated rd1 photoreceptors. (A–C) In
vitro-differentiated photoreceptors derived from wt retinas stained with
antibodies anti-rhodopsin (Rho, green), anti-phosphodiesterase6 (Pde6b,
blue), and anti-rod cGMP-gated ion channel -subunit (Cnga, red). wt cells
express the three rod-specific markers. (Scale bar, 20 m.) (D–L) wt (D–F) and
rd1 (G–L) differentiated photoreceptors were triple stained with anti-
rhodopsin (red), anti-Pde6b (blue), anti-Cnga (red), and TUNEL (green).
Merged images are shown in F, I, and L. (M–O) In vitro-differentiated rd1
retinal cells were double stained with TUNEL (green) and antibodies for the
amacrine cell marker syntaxin (M), the bipolar cell marker Pkc (N), or the
horizontal cell marker calbindin (O). Nuclei were stained with DAPI (blue).
Cells that undergo apoptosis (arrows) do not express markers of amacrine,
bipolar, and horizontal retinal cells. (Scale bar, 10 m.)
Fig. 3. Correlation among Ca2 levels, calpain activation, and AIF and
caspase-12 nuclear translocation in rd1 apoptotic cells. (A–H) Differentiated
retinal cells from wt (A–D) and rd1 (E–H) mice triple stained with anti-AIF
(blue), anti-caspase-12 (red), and TUNEL (green). Merged images are shown in
D andH. AIF and caspase-12 in rd1 TUNEL-positive cells are detected inside the
nuclei (arrows in E–H). (Scale bar, 10 m.) (I and J) wt (I) and rd1 (J) in
vitro-differentiated retinal cells double stained with anti-cytochrome c (red)
and TUNEL (green). Nuclei were counterstained with DAPI (blue). (Scale bar,
2 m.) (K and L) wt (K) and rd1 (L) in vitro-differentiated retinal cells were
double stained with anti-caspase-12 (red) and anti-ERAB (green). (M and N)
Pseudocolored images analyzing intracellular Ca2 distribution in wt (M) and
rd1-differentiated (N) retinal cells. Brown represents high Ca2, and blue
represents low Ca2 concentrations. (Scale bar, 20 m.) (O) Statistical analysis
of fluorescence intensity at different culture times (D, day) shows a 3-fold
increment of intracellular Ca2 in rd1 cells after 11 days in culture. Treatment
with a calcium channel blocker, cis-diltiazem, prevents Ca2 increase (D11dtz).
Fluorescence intensity was reported as the mean amplitude of 20 different
transversal layers of 20 cells. (P) Colabeling of rd1-differentiated retinal cells
with TUNEL (red) and a substrate measuring calpain activity (blue). Arrows
indicate cells with active calpains but that are not yet TUNEL-positive. (Q)
Percentage of positive cells at 9, 10, and 11 days of culture: high Ca2 (yellow),
calpain activation (light blue), nuclear AIF (dark blue), nuclear caspase-12
(red), and TUNEL (green). (R) Quantitative real-time PCR shows increased
Caspase-12 mRNA levels in rd1 cells.
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nonspecific effects of shRNAs, we designed a second shRNA for
each gene and confirmed that off-target effects are not responsible
for the observed phenotype. Furthermore, down-regulation of AIF
did not affect subcellular localization of mitochondrial cytochrome
c, and down-regulation of caspase-12 did not affect ER marker
ERAB (Fig. 8, which is published as supporting information on the
PNAS web site). Mutagenized shRNAs were used as controls (Fig.
4A–C andG–I).WhenAIFwas down-regulated, a reduced number
of photoreceptors showed caspase-12 translocation to the nucleus
(Fig. 4 E, arrows, and M), and no chromatin fragmentation could
be detected by TUNEL staining (Fig. 4 F and M). Conversely,
down-regulation of caspase-12 only slightly reduced the percentage
of dying cells (30% reduction, Fig. 4N), and all cells undergoing
apoptosis showed nuclear localization of AIF, suggesting a primary
role of AIF in this apoptotic event (Fig. 4 J–N). AIF is therefore
necessary to activate apoptosis, whereas translocation of caspase-12
is not sufficient to induce apoptosis in photoreceptor cells. Similar
results were obtainedwith the second shRNAs targeting eitherAIF
or caspase-12 (Fig. 8).
Knockdown experiments suggested that mitochondrial and ER
pathways are activated independently; however, the two pathways
interact by reinforcing each other, as indicated by the reduced
number of photoreceptors with nuclear localization of caspase-12 in
AIF cells or AIF in casp-12 cells.
Calcium Channel Blocker Interferes with AIF and Caspase-12 Activa-
tion. To confirm that changes in Ca2 homeostasis cause AIF and
caspase-12 relocalization, we treated rd1 pups with the calcium
channel blocker cis-diltiazem, a drug reported to be able to slow
retinal degeneration in rd1 mice (26). A significant decrease of
apoptotic nuclei was found at P11. However, TUNEL-positive cells
were still detectable, and histological analysis of cis-diltiazem-
treated rd1 retinas defined advanced degeneration at P21 (Fig. 5I
and data not shown). No nuclear translocation of either AIF or
caspase-12 was detectable by triple staining of cis-diltiazem-treated
rd1 retinas (Fig. 5 A–D). We also detected a strong decrease of
activated AIF and caspase-12 fragments in the nuclear fraction of
retinas treated with the calcium blocker (Fig. 5K). cis-diltiazem was
also able to reduce apoptosis in vitro (Fig. 5J) and prevented AIF
and caspase-12 translocation to the nucleus (data not shown). These
data implied that changes in Ca2 concentration are strictly linked
to activation of multiple apoptotic pathways in rd1 retinas.
Calpain Inhibitors Interfere with AIF and Caspase-12 Activation and
Block Apoptosis in the rd1 Retina.Cleavage and release of AIF from
the mitochondria is mediated by calpain I (18), whereas caspase-12
is processed by calpain II (10). Based on this evidence, we reasoned
that by blocking both calpain activities, we might prevent AIF and
caspase-12 activation and, consequently, apoptosis. We intravitre-
ously injected rd1 eyes with either calpain inhibitors I (ALLN) or
II (ALLM) or a mixture of both. We injected calpain inhibitors at
concentrations reported for the eye (7). After treatment with both
calpain inhibitors, wewere unable to detect apoptotic cells in the rd1
retina or in in vitro-differentiated photoreceptors (Fig. 5 G–I). In
vivo treatments with ALLM or ALLN were not as effective as with
the two inhibitors together (Fig. 5I). We never detected AIF and
caspase-12 inside photoreceptor nuclei treated with ALLN and
ALLM (Fig. 5 E–H). Western blot analysis confirmed that treat-
ment with ALLN and ALLM was inhibiting AIF and caspase-12
activation (Fig. 5K). On the contrary, in vivo and in vitro treatment
of rd1 photoreceptors with pancaspase inhibitor zVAD.fmk had
only a minor effect in preventing apoptosis and did not prevent
nuclear localization of AIF and caspase-12 (Fig. 5 I and J and L
and M).
Discussion
During the last 20 years, the molecular causes of RP were unrav-
eled, and apoptosis was identified as the common mechanism
causing photoreceptor demise in this genetically heterogeneous
disease. Nevertheless, important questions on programmed cell
death remained unsolved, and little is known about the apoptotic
molecules activated in retinal degeneration. Here, we molecularly
characterized apoptosis in photoreceptors with Pde6b gene inacti-
vation. We report concomitant translocation to the nucleus of a
mitochondrial protein, AIF, and of a caspase normally localized to
the ER.
Fig. 4. Apoptosis in rd1 in vitro-differentiated photoreceptors in the ab-
sence of either AIF or caspase-12. Retinal cells from rd1 mice were infected
with retroviruses carrying AIF control shRNA (A–C, contr.AIF), AIF shRNA
(D–F, AIF), caspase-12 control shRNA (G–I, contr.casp-12), and caspase-12
shRNA (J–L, casp-12). Cells were triple stained with anti-AIF (blue), anti-
caspase-12 (red), and TUNEL (green). Merged images are shown in Insets of C,
F, I, and L (merged). (Scale bar, 10m.) (M andN) Percentage of TUNEL- (green
bars), caspase-12- (red bars), and AIF- (blue bars) positive nuclei of retinal stem
cells infected with shRNA retroviruses targeting AIF (M) or caspase-12 (N). The
values represent the average of nine different experiments. P 0.001. (O and
P) Western blotting of total proteins purified from RNAi experiments target-
ing either AIF (O) or caspase-12 (P) show complete down-regulation of these
proteins. Uninf, samples of cells not treated with any shRNA retrovirus; cont,
control shRNA. Western blots were normalized with the -tubulin (-tub).
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We observed that cotranslocation of AIF and caspase-12 in
apoptotic photoreceptor nuclei follows increase of intracellular
Ca2 and calpain activation. The strict correlation with changes in
Ca2 homeostasis was confirmed by treatment with the calcium-
channel blocker cis-diltiazem, whichwas able to reduce intracellular
Ca2, interferewith translocation to the nucleus of both factors, and
reduce apoptosis. We still cannot explain why the drug was unable
to abolish apoptosis in vivo. The efficacy of cis-diltiazem in pro-
tecting against photoreceptor apoptosis is still controversial. Some
studies provided evidence of photoreceptor rescue (26). In contrast,
other studies did not detect beneficial effects in this same model
(27) or in a canine model (28). By calculating the number of
apoptotic cells during cis-diltiazem treatment, we detected some
beneficial effect at early stages during the degenerative process;
however, this drug was unable to completely block apoptosis, and
the retina eventually underwent complete degeneration. We think
that the in vivo treatment of mice with cis-diltiazem does not allow
all photoreceptors to be exposed to the proper concentration,
whereas the in vitro studies allow a more homogeneous exposure to
the drug. Secondly, cis-diltiazem blocks all calcium channels and
therefore deeply changes photoreceptor metabolism and interac-
tions with adjacent cells, and this change may hamper the positive
effects of the drug.
More interestingly, RNAi experiments implied that the two
apoptotic factors are independently activated but partially affect
each other. In fact, translocation to the nucleus of either AIF or
caspase-12 can still be detected in the absence of the other factor,
but in a low percentage of cells. We also demonstrated that AIF
plays a crucial role in the apoptotic event of photoreceptor cells,
whereas caspase-12 has a marginal role. In fact, down-regulation of
this protein only partially rescues cells from apoptosis. Unfortu-
nately, in vivo down-regulation of AIF cannot be tested because it
causes degeneration of cerebellar and retinal neurons in the Har-
lequin mouse (29). It is therefore important to develop a system
able to prevent AIF translocation to the nucleus without impairing
its important physiological functions in the mitochondria. Our in
vivo positive results with calpain-inhibitor treatments are the first
attempt toward this aim and demonstrate the effectiveness of these
drugs in blocking AIF activation. Our results are in line with the
study showing a beneficial effect of different calpain inhibitors in
retinal explant cultures (8), whereas it is not in agreement with a
report showing no effect on photoreceptor degeneration by treat-
ment with the calpain inhibitor ALLN (5). This discrepancymay be
due to differences in the technical approaches used: Doonan et al.
used retinal explants, whereas we treated mice in vivo; second, we
used a mixture of two calpain inhibitors with high concentrations
that are not toxic for the retina in vivo.
How can we explain the 20% of photoreceptors in which we did
not observe AIF and caspase-12 translocation to the nucleus? We
cannot exclude that our in situ detection of AIF and caspase-12 fails
to detect low amounts of these factors in some apoptotic nuclei. In
fact, photoreceptors in an advanced apoptotic status may degrade
intracellular proteins like AIF and caspase-12, whereas the nucleus
can still be labeled by TUNEL. We can also postulate that a third
apoptotic pathway is activated in different photoreceptors, either
independently or as a consequence of cell death in the surrounding
cells. Theminor effect of pancaspase inhibitor in reducing apoptosis
in vivo and in vitro but not in preventingAIF and caspase-12 nuclear
translocation may support this hypothesis; however, it may also
imply a partial, but not key, function of effector caspases, as
suggested (23).
In conclusion, the option of exploiting apoptosis as a therapeutic
target is complex. Nevertheless, themolecular understanding of the
different apoptotic factors activated during degeneration and the
Fig. 5. In vivo and in vitro treatment of rd1 photoreceptors with cis-diltiazem and calpain inhibitors. (A–D) P11 rd1 retina treated with cis-diltiazem and triple
stained with anti-AIF (blue), anti-caspase-12 (red), and TUNEL (green). The merged image is shown inD. (D Inset) Enlargement of the selected area is shown. (Scale
bar, 100 m.) (E–H) P11 rd1 retina treated with ALLN and ALLM calpain inhibitors. Sections were triple stained with anti-AIF (blue), anti-caspase-12 (red), and
TUNEL (green). The merged image is shown in H. (I and J) Counts of apoptotic photoreceptors in rd1 retinas (I) and in in vitro-differentiated apoptotic
photoreceptors (J) either untreated (untr.) or treated with cis-diltiazem (dtz), ALLN (ALLN), ALLM (ALLM), ALLNALLM (ALLN ALLM), or zVAD.fmk (zvad). The
y axis in I represents mean values counted in six sections of six different mice. The y axis in J represents mean values counted in six different experiments. (K)
Western blot analysis of nuclear-enriched lysates purified from P11 rd1 (rd1), rd1 cis-diltiazem treated (dtz) and rd1-calpain inhibitor-treated (ALLNALLM)
retinas. Western blots were normalized with the nuclear marker acetyl-histone H3 (H3). (L) retina section from a P11 rd1 mouse intravitreally injected with
zVAD.fmk and triple stained with TUNEL (green), anti-AIF antibodies (blue), and anti-caspase-12 antibodies (red). Arrows indicate cotranslocation of AIF and
caspase-12 inside photoreceptor nuclei. (M) In vitro-differentiated rd1 photoreceptors treated with zVAD.fmk (zvad) and stained with TUNEL (green), anti-AIF
antibodies (blue), and anti-caspase-12 antibodies (red). Arrows indicate cotranslocation of AIF and caspase-12 inside apoptotic photoreceptor nuclei.
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identification of common activators are the first steps toward this
goal. Our studies report an in vivo molecular characterization of
apoptosis in rd1 mice and identify AIF and caspase-12 as the
apoptotic factors triggering photoreceptor cell demise. Coactivation
of these two pathways may be involved in other forms of neuronal
degenerations in which either AIF or caspase-12 were shown to be
required (9, 11, 12, 30). We had demonstrated that the mitochon-
drial and ER pathways are engaged together in ER stress-activated
apoptosis (25). Further studies will be necessary to define whether
this mechanism is a common pathway triggered also in dominant
forms of retinal degeneration caused by ER retention of mutant
protein. Importantly, we defined that common activators, such as
calpains, act on both mitochondrial and ER factors during the
degenerative process. The efficacy of ALLN and ALLM in inter-
fering with apoptosis and relocalization of AIF and caspase-12
opens new perspectives for designing therapeutic approaches to
rescue photoreceptor cell death.
Materials and Methods
Mice and Treatments. All procedures on mice were performed in
accordance with institutional guidelines for animal research. C3H
HeN (rd1) and CBA mice (genetic background of C3HHeNCrl)
were purchased from Charles River Italia (Calco, Italy). For
intravitreal administration, calpain inhibitor I (ALLN, 10 nmol per
eye, 1 mM final concentration) and II (ALLM, 2 nmol per eye,
200 M final concentration) or zVAD.fmk (25 ng per eye) were
delivered intravitreusly by a transscleral transchoroidal approach at
P10. Control eyes received vehicle only (DMSO). I.p. injections of
D-cis-diltiazem in rd1mice were performed as reported, starting at
P7 (26). Treated mice were analyzed at P11. Adult C57BL6 mice
were i.p.-injected with a 70 mgkg single dose of N-methyl-N-
nitrosourea. Animals were killed 24 h after treatment.
Retinal Cell Culture Preparation and Differentiation. Retinal stem
cells were isolated from adult mice and cultured as described (24).
Retinal neurosphereswere allowed to differentiatewith 1%FBSon
a substrate of laminin (2.5 gml) and polyD-lysine (20 gml).
Seventy percent of photoreceptor differentiation was obtained by
treatment with 500 nM retinoic acid for 11 days. Wt and rd1-
differentiated retinal cells were treated with ALLN (25 M),
ALLM (5 M), zVAD.fmk (50 M), and D-cis-diltiazem (5 mM)
for 12 h before analysis.
DNA Nick-End Labeling by the TUNEL Method and Immunofluores-
cence. Apoptotic nuclei were detected by TdT-mediated dUTP
terminal nick-end labeling kit (TUNEL). Calpain activity was
revealed as reported (5, 8). The primary antibodies used were:
anti-AIF, anti-caspase-12, anti-rhodopsin (Ret-P1), anti- subunit
of protein kinase c (Pkc), anti-Syntaxin, anti-Calbindin, all from
Sigma (St. Louis, MO), anti-Pde6b from Abcam (Cambridge,
U.K.), and anti-Cnga (31, 32).
Quantitative RT-PCR. The Real-time PCRwas performed by using,
as primers for Casp-12 gene, casp-F: 5-TTGCTTTCAAATCT-
TCTACCCCA and casp-R: 5-GGAAATGAAGAGGGAAC-
CAGTCTT and for S26 reference gene, S26F: 5-AAGTTT-
GTCATTCGGAACATT and S26R: 5-GATCGATTCCTAA-
CAACCTTG.
Calcium Ion Concentration Measurement. Fluo-4, AM (Molecular
Probes, Eugene, OR) was loaded into differentiated photoreceptor
cells for 30 min at 37°C in Ca2-free medium. Cells were excited by
using a 488-nm laser beam and analyzed with a Laser Confocal
Microscope System (Leica, Wetzlar, Germany). Twenty sequential
layers of each cell were photographed. Images were then analyzed
with the Leica confocal software (LCS). The fluorescence average
intensity (mean amplitude) of each area was measured.
Western Blotting Analysis.Retinas were lysed as described (25). The
antibodies used for Western blotting were anti-AIF (Oncogene,
Cambridge, MA) and anti-caspase-12 (Cell Signaling Technology,
Beverly, MA).
RNAi. Target sequences for caspase-12mRNA were 5-AAUGAU-
GAGGAUGAUGGACCU and 5-AACCCAAGAUUCUCAU-
CAUGC. Control hairpin RNAi template oligonucleotides were
generated by mutagenizing three nucleotides (in bold) in the
targeting sequence: AATGCCGCGGATGATGGACCT. Target-
ing sequences for AIF were 5-UUGUUCCAGCAAUGGCGUG
and 5-CUUGUUCCAGCAAUGGCGU.As control, wemutated
three nucleotides (in bold) in the targeting sequence: TTCTTCTA-
GAAATGGCGTG. Sense and antisense oligonucleotides were
annealed to form a hairpin siRNA template insert and were cloned
into the pSUPER Maloney-derived retroviral vector. Retinal cell
cultures were infected at day 4 of differentiation with retroviruses
obtained by transient transfection in HEK293T cells and diluted
1:100. Cells were analyzed 6 days later.
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